Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Martin

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Viruses|January 26, 2024
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in MiceJackelyn Murray, David E Martin, Sarah Hosking, et al.
International Journal of Molecular Sciences|November 27, 2024
Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus ResponseLes P Jones, Harrison C Bergeron, David E Martin, et al.
Cureus|January 30, 2023
Large Mucocele of the Appendix Discovered in a 48-Year-Old Male Presenting With Appendicitis: A Case ReportDimitar I Semerdzhiev, Robert E Hardister, Stephen D Wagner, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteersDavid E Martin, Robert Blum, John Wilton, et al.
Cureus|August 15, 2023
Drug-Induced Thrombocytopenia: A Case Involving VancomycinAlexander Barnecet Pérez, Caleb A Niehues, Courtney M Hicks, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2007
Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infectionPatrick F Smith, Abayomi Ogundele, Alan Forrest, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2005
Anti-AIDS agents 65: investigation of the in vitro oxidative metabolism of 3',4'-Di-O-(-)-camphanoyl-(+)-cis-khellactone derivatives as potent anti-hiv agentsMadoka Suzuki, Yutai Li, Philip C Smith, et al.
Viruses|May 28, 2022
Probenecid Inhibits Respiratory Syncytial Virus (RSV) ReplicationJackelyn Murray, Harrison C Bergeron, Les P Jones, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIVDonglei Yu, Carl T Wild, David E Martin, et al.
Plos One|November 29, 2007
Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv miceCheryl A Stoddart, Pheroze Joshi, Barbara Sloan, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Viruses|January 26, 2024
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in MiceJackelyn Murray, David E Martin, Sarah Hosking, et al.
International Journal of Molecular Sciences|November 27, 2024
Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus ResponseLes P Jones, Harrison C Bergeron, David E Martin, et al.
Cureus|January 30, 2023
Large Mucocele of the Appendix Discovered in a 48-Year-Old Male Presenting With Appendicitis: A Case ReportDimitar I Semerdzhiev, Robert E Hardister, Stephen D Wagner, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteersDavid E Martin, Robert Blum, John Wilton, et al.
Cureus|August 15, 2023
Drug-Induced Thrombocytopenia: A Case Involving VancomycinAlexander Barnecet Pérez, Caleb A Niehues, Courtney M Hicks, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2007
Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infectionPatrick F Smith, Abayomi Ogundele, Alan Forrest, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2005
Anti-AIDS agents 65: investigation of the in vitro oxidative metabolism of 3',4'-Di-O-(-)-camphanoyl-(+)-cis-khellactone derivatives as potent anti-hiv agentsMadoka Suzuki, Yutai Li, Philip C Smith, et al.
Viruses|May 28, 2022
Probenecid Inhibits Respiratory Syncytial Virus (RSV) ReplicationJackelyn Murray, Harrison C Bergeron, Les P Jones, et al.
Expert Opinion on Investigational Drugs|July 12, 2005
The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIVDonglei Yu, Carl T Wild, David E Martin, et al.
Plos One|November 29, 2007
Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv miceCheryl A Stoddart, Pheroze Joshi, Barbara Sloan, et al.
Pageof 7